AMR Surveillance in Africa: Are We There Yet?

Delineating the burden of antimicrobial resistance (AMR), detecting outbreaks due to multidrug resistant-bacteria and monitoring AMR trends for the early warning of emerging/escalating AMR in humans, animals, plants and the environment requires high-quality AMR surveillance systems that generate rep...

Full description

Saved in:
Bibliographic Details
Main Authors: Prof Sabiha Essack, Sabiha Y. Essack
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971225000529
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850043484473393152
author Prof Sabiha Essack
Sabiha Y. Essack
author_facet Prof Sabiha Essack
Sabiha Y. Essack
author_sort Prof Sabiha Essack
collection DOAJ
description Delineating the burden of antimicrobial resistance (AMR), detecting outbreaks due to multidrug resistant-bacteria and monitoring AMR trends for the early warning of emerging/escalating AMR in humans, animals, plants and the environment requires high-quality AMR surveillance systems that generate representative, quality-assured data. AMR surveillance in Africa is largely laboratory-based and generates phenotypic data on causative bacterial pathogens and their susceptibility to a panel of antibiotics. Data reliability and validity, fidelity of laboratory methods and quality assurance are frequently cited limitations raising concerns on the utility of phenotypic AMR surveillance data for policy and practice action.Genomic AMR surveillance in Africa is limited to discrete research projects at Universities and research institutions that describe the resistome, mobilome, virulome and phylogeny using whole genomic sequencing and open-source bioinformatics tools in the main and genomic surveillance capacity is steadily increasing on the content. Genomic surveillance has showcased the mobility and fluidity of drug-resistant bacterial strains, antimicrobial resistance genes and their associated mobile genetic elements within and between humans, animals and the environment although regional phylogenomics is limited by the number of countries and the number and quality of whole genomes uploaded on open source databases. The concerns related to phenotypic and genomic data correlations, high costs, unstable supply chains and competing health priorities in resource-constrained settings precludes genomic surveillance becoming part of national AMR surveillance systems in Africa at this time. Countries should optimize the quality and representativeness of phenotypic surveillance and leverage the expansion in genomic capacity as a result of the COVID-19 pandemic to advance genomic AMR surveillance in Africa.
format Article
id doaj-art-ab7c9dc1f5c74125839fef1d4fc025b9
institution DOAJ
issn 1201-9712
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series International Journal of Infectious Diseases
spelling doaj-art-ab7c9dc1f5c74125839fef1d4fc025b92025-08-20T02:55:13ZengElsevierInternational Journal of Infectious Diseases1201-97122025-03-0115210782810.1016/j.ijid.2025.107828AMR Surveillance in Africa: Are We There Yet?Prof Sabiha Essack0Sabiha Y. Essack1University of KwaZulu-Natal, KwaZulu-Natal, South AfricaAntimicrobial Research Unit, School of Health Sciences, University of KwaZulu-Natal, Durban, South AfricaDelineating the burden of antimicrobial resistance (AMR), detecting outbreaks due to multidrug resistant-bacteria and monitoring AMR trends for the early warning of emerging/escalating AMR in humans, animals, plants and the environment requires high-quality AMR surveillance systems that generate representative, quality-assured data. AMR surveillance in Africa is largely laboratory-based and generates phenotypic data on causative bacterial pathogens and their susceptibility to a panel of antibiotics. Data reliability and validity, fidelity of laboratory methods and quality assurance are frequently cited limitations raising concerns on the utility of phenotypic AMR surveillance data for policy and practice action.Genomic AMR surveillance in Africa is limited to discrete research projects at Universities and research institutions that describe the resistome, mobilome, virulome and phylogeny using whole genomic sequencing and open-source bioinformatics tools in the main and genomic surveillance capacity is steadily increasing on the content. Genomic surveillance has showcased the mobility and fluidity of drug-resistant bacterial strains, antimicrobial resistance genes and their associated mobile genetic elements within and between humans, animals and the environment although regional phylogenomics is limited by the number of countries and the number and quality of whole genomes uploaded on open source databases. The concerns related to phenotypic and genomic data correlations, high costs, unstable supply chains and competing health priorities in resource-constrained settings precludes genomic surveillance becoming part of national AMR surveillance systems in Africa at this time. Countries should optimize the quality and representativeness of phenotypic surveillance and leverage the expansion in genomic capacity as a result of the COVID-19 pandemic to advance genomic AMR surveillance in Africa.http://www.sciencedirect.com/science/article/pii/S1201971225000529
spellingShingle Prof Sabiha Essack
Sabiha Y. Essack
AMR Surveillance in Africa: Are We There Yet?
International Journal of Infectious Diseases
title AMR Surveillance in Africa: Are We There Yet?
title_full AMR Surveillance in Africa: Are We There Yet?
title_fullStr AMR Surveillance in Africa: Are We There Yet?
title_full_unstemmed AMR Surveillance in Africa: Are We There Yet?
title_short AMR Surveillance in Africa: Are We There Yet?
title_sort amr surveillance in africa are we there yet
url http://www.sciencedirect.com/science/article/pii/S1201971225000529
work_keys_str_mv AT profsabihaessack amrsurveillanceinafricaarewethereyet
AT sabihayessack amrsurveillanceinafricaarewethereyet